# Lars Hendrik Müschen

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/lars-hendrik-muschen/

## Facts

| Field | Value |
| --- | --- |
| Citations | 582 |
| Field | Neurogenetic and Muscular Disorders Research |
| h-index | 12 |
| i10-index | 12 |
| Last Known Institution | Medizinische Hochschule Hannover |
| OpenAlex ID | https://openalex.org/A5008157372 |
| ORCID iD | 0000-0003-2805-3270 |
| Works | 23 |

## Researcher papers

- [Ocrelizumab Depletes CD20+ T Cells in Multiple Sclerosis Patients](https://scholariq.org/papers/ocrelizumab-depletes-cd20-t-cells-in-multiple-sclerosis-patients/)
- [Impaired Quality of Life and Need for Palliative Care in a German Cohort of Advanced Parkinson’s Disease Patients](https://scholariq.org/papers/impaired-quality-of-life-and-need-for-palliative-care-in-a-german-cohort-of/)
- [Informal Caregiving in Amyotrophic Lateral Sclerosis (ALS): A High Caregiver Burden and Drastic Consequences on Caregivers’ Lives](https://scholariq.org/papers/informal-caregiving-in-amyotrophic-lateral-sclerosis-als-a-high-caregiver-burden/)
- [Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis](https://scholariq.org/papers/current-state-and-future-directions-in-the-diagnosis-of-amyotrophic-lateral/)
- [Treatment expectations and patient-reported outcomes of nusinersen therapy in adult spinal muscular atrophy](https://scholariq.org/papers/treatment-expectations-and-patient-reported-outcomes-of-nusinersen-therapy-in/)
- [Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study](https://scholariq.org/papers/improved-upper-limb-function-in-non-ambulant-children-with-sma-type-2-and-3/)
- [Costs of illness in amyotrophic lateral sclerosis (ALS): a cross-sectional survey in Germany](https://scholariq.org/papers/costs-of-illness-in-amyotrophic-lateral-sclerosis-als-a-cross-sectional-survey/)
- [Routine Cerebrospinal Fluid Cytology Reveals Unique Inclusions in Macrophages During Treatment With Nusinersen](https://scholariq.org/papers/routine-cerebrospinal-fluid-cytology-reveals-unique-inclusions-in-macrophages/)
- [Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients](https://scholariq.org/papers/cerebrospinal-fluid-parameters-in-antisense-oligonucleotide-treated-adult-5q/)
- [Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy](https://scholariq.org/papers/treatment-satisfaction-in-5q-spinal-muscular-atrophy-under-nusinersen-therapy/)

## Researcher topics

- [Neurogenetic and Muscular Disorders Research](https://scholariq.org/topics/neurogenetic-and-muscular-disorders-research/)
- [Amyotrophic Lateral Sclerosis Research](https://scholariq.org/topics/amyotrophic-lateral-sclerosis-research/)
- [Regulation of Appetite and Obesity](https://scholariq.org/topics/regulation-of-appetite-and-obesity/)
- [Spinal Dysraphism and Malformations](https://scholariq.org/topics/spinal-dysraphism-and-malformations/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

## Researcher university

- [Medizinische Hochschule Hannover](https://scholariq.org/institutions/medizinische-hochschule-hannover/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.